Community Series in Research Advances of Tuberculosis Vaccine and its Implication on COVID-19: Volume III

4,220
Total downloads
19k
Total views and downloads

Articles

REVIEW

Published on 22 Oct 2025

Different antibody isotypes against tuberculosis: what we know and what we need to know

Huoming Li
Hao Li

doi 10.3389/fimmu.2025.1682934

1,657 views

CORRECTION

Published on 25 Aug 2025

Correction: BCG and beyond: unlocking new frontiers in TB vaccine development

Aishwarya Shaji
Akanksha Verma
Ashima Bhaskar
Ved Prakash Dwivedi

doi 10.3389/fimmu.2025.1677868

888 views

ORIGINAL RESEARCH

Published on 30 Jul 2025

Experimental validation of cuproptosis-associated molecular signatures and their immunological implications in pulmonary tuberculosis

Xiaofang Liu
Qianqian Ma
Zhiming Li
Yong Xue
Jie Mi
Yuxi Li
Chunfeng Bai
Donglin Guo
Yinping Liu
2 more
Xueqiong Wu

doi 10.3389/fimmu.2025.1570992

1,735 views

REVIEW

Published on 30 Jul 2025

BCG and beyond: unlocking new frontiers in TB vaccine development

Aishwarya Shaji
Akanksha Verma
Ashima Bhaskar
Ved Prakash Dwivedi

doi 10.3389/fimmu.2025.1608104

3,082 views
1 citation

CORRECTION

Published on 30 Apr 2025

Corrigendum: Enhancing cell-mediated immunity through dendritic cell activation: the role of Tri-GalNAc-modified PLGA-PEG nanoparticles encapsulating SR717

Yang Gong
Hongbin Jia
Wenrui Dang
Ting Zhou
Pu He
Xiaolei Wang
Bingdong Zhu

doi 10.3389/fimmu.2025.1590490

1,093 views

ORIGINAL RESEARCH

Published on 07 Mar 2025

Screening and preclinical assessment of novel Mycobacterium tuberculosis recombinant antigens based tuberculin skin testing

Xichao Ou
Eryong Liu
Faiqa Rashid
Shaojun Pei
Guoqin Zhang
Richard Anthony
Ruida Xing
Fei Huang
Hui Xia
7 more
Yanlin Zhao

doi 10.3389/fimmu.2025.1498448

2,362 views
3 citations

ORIGINAL RESEARCH

Published on 23 Dec 2024

Enhancing cell-mediated immunity through dendritic cell activation: the role of Tri-GalNAc-modified PLGA-PEG nanoparticles encapsulating SR717

Yang Gong
Hongbin Jia
Wenrui Dang
Ting Zhou
Pu He
Xiaolei Wang
Bingdong Zhu

doi 10.3389/fimmu.2024.1490003

2,384 views
2 citations

ORIGINAL RESEARCH

Published on 04 Dec 2024

Investigation of the prevalence of latent tuberculosis in cancer patients compared to non-cancer patients: a case-control study

Masoud Mortezazadeh
Mehdi Karimi
Mohsen Esfandbod
Abbas Mofidi
Nima Hemmati
Mehdi Kashani
Niyousha Shirsalimi
Seyyed Taher Seyyed Mahmoudi
Ehsan Kamali Yazdi

doi 10.3389/or.2024.1445678

2,273 views
2 citations

Share on

Frontiers in Immunology

Vaccines and Molecular Therapeutics

Other participating journals

Frontiers in Tuberculosis
- Immunological Basis of Tuberculosis

Impact

19kTopic views
14kArticle views
4,220Article downloads

View impact

Articles

Different antibody isotypes against tuberculosis: what we know and what we need to know

Correction: BCG and beyond: unlocking new frontiers in TB vaccine development

Experimental validation of cuproptosis-associated molecular signatures and their immunological implications in pulmonary tuberculosis

BCG and beyond: unlocking new frontiers in TB vaccine development

Corrigendum: Enhancing cell-mediated immunity through dendritic cell activation: the role of Tri-GalNAc-modified PLGA-PEG nanoparticles encapsulating SR717

Screening and preclinical assessment of novel Mycobacterium tuberculosis recombinant antigens based tuberculin skin testing

Enhancing cell-mediated immunity through dendritic cell activation: the role of Tri-GalNAc-modified PLGA-PEG nanoparticles encapsulating SR717

Investigation of the prevalence of latent tuberculosis in cancer patients compared to non-cancer patients: a case-control study

Frontiers in Immunology

Vaccines and Molecular Therapeutics

Other participating journals

Frontiers in Tuberculosis

Immunological Basis of Tuberculosis